Heterogeneity of Kras status in primary colorectal cancer and corresponding liver metastases.

被引：0
|
作者：
Kaneko, Y. [1 ]
Kuramochi, H. [1 ]
Nakajima, G. [1 ]
Nakamura, A. [1 ]
Inoue, Y. [1 ]
Hayashi, K. [1 ]
Yamamoto, M. [1 ]
机构：
[1] Tokyo Womens Med Univ, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e14037
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14037
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Heterogeneity in Colorectal Primary Tumor and Synchronous Liver Metastases
    Shubin, V. P.
    Ponomarenko, A. A.
    Tsukanov, A. S.
    Maynovskaya, O. A.
    Rybakov, E. G.
    Panina, M. V.
    Kashnikov, V. N.
    Frolov, S. A.
    Shelygin, Yu. A.
    RUSSIAN JOURNAL OF GENETICS, 2018, 54 (06) : 698 - 702
  • [32] Proteome biology of primary colorectal carcinoma and corresponding liver metastases
    Fahrner, Matthias
    Bronsert, Peter
    Fichtner-Feigl, Stefan
    Jud, Andreas
    Schilling, Oliver
    NEOPLASIA, 2021, 23 (12): : 1240 - 1251
  • [33] Can the mutational status of KRAS drive the treatment of colorectal liver metastases?
    Muttillo, Edoardo M.
    Felli, Emanuele
    HPB, 2021, 23 (04) : 643 - 643
  • [34] Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location
    Sasaki, Kazunari
    Margonis, Georgios A.
    Wilson, Ana
    Kim, Yuhree
    Buettner, Stefan
    Andreatos, Nikolaos
    Gani, Faiz
    Amini, Neda
    Spolverato, Gaya
    Pawlik, Timothy M.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (11) : 3736 - 3743
  • [35] Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location
    Kazunari Sasaki
    Georgios A. Margonis
    Ana Wilson
    Yuhree Kim
    Stefan Buettner
    Nikolaos Andreatos
    Faiz Gani
    Neda Amini
    Gaya Spolverato
    Timothy M. Pawlik
    Annals of Surgical Oncology, 2016, 23 : 3736 - 3743
  • [36] Heterogeneity in signaling pathway activity within primary breast cancer and between primary and metastases.
    Verhaegh, Wim
    van Brussel, Anne
    Moelans, Cathy
    de Inda, Marcia Alves
    Gil, Julie
    Bikker, Jan Willem
    den Biezen-Timmermans, Eveline
    Van De Stolpe, Anja
    van Diest, Paul J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Expression Status of Rap1 Pathway-Related Genes in Liver Metastases Compared with Corresponding Primary Colorectal Cancer
    Abbastabar, Maryam
    Allgayer, Heike
    Sepidarkish, Mahdi
    Sadeghi, Farzin
    Ghasemi, Maryam
    Pour-bagher, Roghayeh
    Parsian, Hadi
    CANCERS, 2024, 16 (01)
  • [38] MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors
    De Maglio, Giovanna
    Casagrande, Mariaelena
    Guardascione, Michela
    Fontanella, Caterina
    Lutrino, Stefania Eufemia
    Rihawi, Karim
    Pisa, Federica Edith
    Tuniz, Francesco
    Fasola, Gianpiero
    Pizzolitto, Stefano
    Aprile, Giuseppe
    FUTURE ONCOLOGY, 2015, 11 (08) : 1201 - 1209
  • [39] The role of combined treatment of metastatic colorectal cancer inpatients with liver metastases.
    Trandofilov, Mikhail
    Gridnev, Danila
    Popov, Anatoly
    Sizova, Anna
    Islamova, Dina
    Makarov, Vladislav
    Kostirev, Semen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Nivolumab with ipilimumab for MSI-H colorectal cancer with liver metastases.
    Michalaki, Vasiliki
    Theodosopoulos, Theodosios
    Frangoulidis, George
    Dafnios, Nikolaos
    Papakonstantinou, Ioannis
    Vezakis, Antonios
    Papadimitriou, Christos
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15556 - E15556
12345